CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
82 hedge funds and large institutions have $256M invested in CureVac in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 20 closing their positions.
263% more capital invested
Capital invested by funds: $70.5M → $256M (+$185M)
89% more call options, than puts
Call options by funds: $1.93M | Put options by funds: $1.02M
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
10.32% more ownership
Funds ownership: 6.21% → 16.53% (+10%)
0% more funds holding
Funds holding: 82 → 82 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$107M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$30.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$28.4M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$10.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$9.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$4.45M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.48M |
| 3 |
Morgan Stanley
New York
|
-$927K |
| 4 |
PVI
Pura Vida Investments
New York
|
-$774K |
| 5 |
D.E. Shaw & Co
New York
|
-$698K |
CVAC Hedge Fund Activity: Q1 2023 in Review
82 of the 6,192 institutional investors tracked by Wall St. Rank reported a position in CureVac (CVAC) for Q1 2023, worth a combined $256M — up 263% from $70.5M a quarter earlier.
Fund positioning in CVAC was balanced in Q1 2023: 20 funds opened new positions, 20 closed out, 27 added to existing stakes and 23 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $107M. The largest seller was Marshall Wace, cutting an estimated $4.45M.
- 82 institutional investors held CureVac (CVAC) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $256M of CureVac stock for Q1 2023, up 263% quarter-over-quarter.
- 20 funds opened new CureVac positions in Q1 2023 and 20 closed out, a net change of 0 holders.
- The largest CureVac buyer in Q1 2023 was RA Capital Management, an estimated $107M added.
- The largest CureVac seller in Q1 2023 was Marshall Wace, an estimated $4.45M sold.
Based on aggregated 13F filings for Q1 2023.